PI3K / AKT / mTOR inhibitor series

PI3K / AKT / mTORRefresh recommended

Morpholino-pyrimidine PI3K pharmacophore to isoform-selective PI3K, AKT, and mTOR inhibitors.

Mechanism · PI3K / AKT / mTOR BioMoa · PI3K / AKT / mTOR BioMoa bridge · shared ID

Last analysis: 7/20/2026, 2:09:58 AM · 2 weeks cadence · refresh on /analyze · refresh recommended

Data sources: Catalog seed
Last updated: 7/20/2026, 2:09:58 AM
Similarity method: Morgan fingerprint, radius 2, 2048 bits, Tanimoto
Verified / known compounds: 5
Exploratory nodes: 1
Abstract scaffolds: 1
Relationship types: Derived (curated) · Fingerprint similarity · Drug-class link

StructureMoa is a chemical-structure exploration tool. Structural similarity, clustering, and SAR relationships are intended for research exploration and do not establish shared potency, selectivity, safety, efficacy, or clinical performance.

Spider Web · Flow · Structure table · Compare · SMILES map

Name, 2D structure, SMILES, role, parent, core similarity, and traits. Click a row for details.

Compound	Role	SMILES	Parent	Core sim.	Traits
Morpholino-pyrimidine PI3K pharmacophoreAbstract pharmacophorepi3k-morpholino-corePage	Scaffold	`c1nc(nc(c1)N1CCOCC1)N`	—	—	PI3K · core · Shared pharmacophore / core scaffold. Anchor for the PI3K / AKT / mTOR inhibitor series li…
Alpelisib (Piqray)Verified drugalpelisibPage	Drug	`CC1=C(C(=CC=C1)F)C2=NC(=NC(=C2)N3CCOCC3)NC…`	Morpholino-pyrimidine PI3K pharmacophore	28%i	approved · PI3Kα · Approved therapeutic. Alpelisib (Piqray) in this family map.
Capivasertib (Truqap)Verified drugcapivasertibPage	Drug	`CC1=CC(=CC(=C1)C2=NC(=NC(=C2)N)NC3=CC=CC(=…`	Morpholino-pyrimidine PI3K pharmacophore	11%i	approved · AKT · Approved therapeutic. Capivasertib (Truqap) in this family map.
Everolimus (Afinitor)Verified drugeverolimusPage	Drug	`COC1CC(CC(C)C2CC(=O)C(C)C=C(C)C(O)C(OC)C(=…`	Morpholino-pyrimidine PI3K pharmacophore	7%i	approved · mTOR · Approved therapeutic. Everolimus (Afinitor) in this family map.
Inavolisib (Itovebi)Verified druginavolisibPage	Drug	`CC1=C(C(=CC=C1)F)C2=NC(=NC(=C2)N3CCOCC3)N4…`	Morpholino-pyrimidine PI3K pharmacophore	29%i	approved · PI3Kα · Approved therapeutic. Inavolisib (Itovebi) in this family map.
Sirolimus (Rapamune)Verified drugsirolimusPage	Drug	`COC1CC(CC(C)C2CC(=O)C(C)=CC(C)C(O)C(OC)C(=…`	Morpholino-pyrimidine PI3K pharmacophore	6%i	approved · mTOR · Approved therapeutic. Sirolimus (Rapamune) in this family map.
PI3K SAR sulfonamide analogExploratory analog (rule-generated)pi3k-sar-sulfonamidePage	Derivative	`CC1=C(C(=CC=C1)F)C2=NC(=NC(=C2)N3CCOCC3)NS…`	Alpelisib (Piqray)	29%i	SAR · SAR exploration node. Derived analog of parent node in PI3K / AKT / mTOR inhibitor series.

From the core chemical, derivatives, drugs, and payloads fan out. Dashed orange chords are drug–drug links (spider web).

Loading map…